期刊文献+

REGgamma在胃癌组织与不同分化胃癌细胞株中的表达及其临床意义

Expression and Clinical Significance of REGgamma in Gastric Cancer Tissue and Various Differentiated Gastric Cancer Cell Lines
下载PDF
导出
摘要 目的:探讨REGgamma(REGγ)在胃癌组织与不同分化细胞株中的表达水平及其临床意义。方法:应用免疫组化SP法检测70例胃癌组织和30例正常胃组织中REGγ/蛋白的表达水平,并分析其与胃癌生物学行为的关系:分别采用逆转录-聚合酶链反应(RT-PCR)及Western blot检测正常胃粘膜细胞株(GES-1)、胃癌高分化(MKN-28)、中分化(SGC-7901)和低分化(BGC823)细胞株中REGγ mRNA转录情况和蛋白表达水平。结果:免疫组化结果表明在胃癌组织中,REGγ蛋白的表达阳性率(74.3%)显著高于正常胃粘膜组织(40.0%,P<0.01),且表达与肿瘤的大小(P<0.01)、淋巴结转移(P<0.05)、分化程度(P<0.01)、浸润程度(P<0.01)及远处转移(P<0.05)相关;RT-PCR结果表明在正常胃粘膜细胞株及胃癌高、中、低分化细胞株中,REGγ mRNA表达水平逐渐增强,分别为0.459±0.079、0.588±0.118、0.715±0.066、0.873±0.099(P<0.01),Western blot结果表明在正常胃粘膜细胞株及胃癌高、中、低分化细胞株中,REGγ蛋白表达水平逐渐增强,分别为0.712±0.065、1.176±0.185、1.533±0.127、2.061±0.398,结果差别有统计学意义(P<0.05)。结论:REGγ在正常胃粘膜组织和胃癌组织中呈一定比例的阳性表达,其表达水平与胃癌癌肿大小、是否有淋巴结转移、分化程度、浸润程度及是否远处转移等肿瘤的恶性生物学行为有关。REGγ表达与胃癌的分化程度相关,随着细胞分化程度的降低其表达逐渐增强,检测REG7 mRNA及蛋白的表达可望成为胃癌早期诊断和判断预后的分子指标之一。 Objective: To evaluate the expression and clinical significance of REGγ in gastric cancer tissue and various differentiated gastric cancer cell lines. Methods: Immunohistochemistry was used to detect the expression of REGγ protein in specimens from 70 cases of gastric cancer and 30 normal gastric mucosa tissue. The correlation between the expression of REGγ protein and the tumor biological behavior was analyzed. RT-PCR and Western blot were used to detect the mRNA levels and the protein expression of REGγ in normal gastric cell line (GES-1), well differentiated gastric cancer cell line (MKN-28), moderately differentiated gastric cancer cell line (SGC-7901) and poorly differentiated gastric cancer cell line (BGC823). Results: Immunohistochemical staining results showed that the positive rate of REGγ protein expression in gastric cancerous tissue (52/70, 74.29%) was significantly higher than that in normal gastric tissue (12/30, 40%) (P〈0.01). The expression of REGy was correlated with tumor size (P〈0.01), lymph node metastasis (P〈0.05), differentiation degree (P〈0.01), invasion degree (P〈0.01), and distant metastasis (P〈0.05). RT-PCR analysis showed that the expression of REGymRNA was (0.459±0.079) in normal gastric mucosa cell line, (0.588±0.118) in well differentiated gastric cancer cell line, (0.715±0.066) in moderately differentiated gastric cancer cell line, and (0.873±0.099) in poorly differentiated gastric cancer cell line, respetively, showing an increasing trend. Western blot analysis showed that the expression of REGy protein was (0.712±0.065) in normal gastric mucosa cell line, (1.176±0.185) in well differentiated gastric cancer cell line, (1.533±0.127) in moderately differentiated gastric cancer cell line and (2.061±0.398) in poorly differentiated gastric cancer cell line, respetively, showing an increasing trend (P〈0.05). Conclusion: There were certain degree of REGy expression in gastric cancer tissues and normal gastric tissue. The expression of REGy was correlated with tumor size, lymph node metastasis, differentiation degree, invasion degree and distant metastasis. The expression of REGy increased gradually in mucosa cell line, well differentiated gastric cancer cell line, moderately differentiated gastric cancer cell line and poorly differentiated gastric cancer cell line. Detection of the expression of REGy mRNA and protein may be useful for the early diagnosis and prognosis evaluation of gastric cancer.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2009年第11期636-639,647,共5页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金资助(编号:30670811)~~
关键词 胃肿瘤 REGgamma 免疫组织化学 基因 蛋白质 Gastric tumor REGgamma Immunohistochemistry Gene Protein
  • 相关文献

参考文献12

  • 1Li X, Lonard DM, Jung SY, et al. The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome[J]. Cell, 2006, 124(2): 381-392.
  • 2Li X, Amazit L, Long W, et al. Ubiquitin-and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway[J]. Mol Cell, 2007, 26(6): 831-842.
  • 3Masson P, Lundgren j, Young P. Drosophila proteasome regulator REGgamma: transcriptional activation by DNA replication-related factor DREF and evidence for a role in cell cycle progression[J].J Mol Biol, 2003, 327(5): 1001-1012.
  • 4Rechsteiner M, Hill CP. Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors[J]. Trends Cell Biol, 2005, 15(1): 27-33.
  • 5Zhang Z, Zhang R. Proteasome activator PA28 gamma regulates p53 by enhancing its MDM2-mediated degradation[J]. EMBO J, 2008, 27(6): 852-864.
  • 6Sharpless NE, DePinho RA. p53: good cop/bad cop[J]. Cell, 2002, 110(1): 9-12.
  • 7Zannini L, Lecis D, Buscemi G, et al. REGgamma proteasome activator is involved in the maintenance of chromosomal stability[J]. Cell Cycle, 2008, 7(4):504-512.
  • 8Baldin V, Militello M, Thomas Y, et al. A novel role for PA28 gamma-proteasome in nuclear speckle organizadon and SR protein trafficking[J]. Mol Biol Cell, 2008, 19(4): 1706-1716.
  • 9田甜,王小毅,李佳,李凡,任国胜.REGgamma基因对乳腺癌细胞MCF-7增殖和凋亡的影响[J].中国肿瘤临床,2008,35(20):1196-1199. 被引量:4
  • 10Okamura T, Taniguchi S, Ohkura T, et al. Abnormally high expression of proteasome activator-gamma in thyroid neoplasm[J]. J Clin Endocrinol Metab, 2003, 88(3): 1374-1383.

二级参考文献11

  • 1游岚瑛,吴明富,史艳燕,陈颖,李琼,魏军成,周剑锋,徐刚,卢运萍,马丁,董恒磊(校对).动力相关蛋白-1(MRP-1/CD9)对卵巢癌细胞体外增殖和运动的影响[J].中国肿瘤临床,2006,33(24):1381-1385. 被引量:1
  • 2Murata S, Kawahara H, Tohma S, et al. Growth retardation in mice lacking the proteasome activator PA28gamma[J]. J Biol Chem, 1999, 274(53):38211-38215.
  • 3Barton LF, Runnels HA, Schell TD, et al. Immune defects in 28-kDa proteasome activator gammadeficient mice[]]. J Immunol, 2004, 172(6):3948-3954.
  • 4Masson P, LundgrenJ, Young P. Drosophila proteasome regulator REGgamma:transcriptional activation by DNA replication-related factor DREF and evidence for a role in cell cycle progression[J].J Mol Biol, 2003, 327(5): 1001-1012.
  • 5Li X, Amazit L, Long W, et al. Ubiquitin-and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway[J].Mol Cell, 2007, 26(6): 831-842.
  • 6Chen X, Barton LF, Chi Y, et al. Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome[J].Mol Cell, 2007, 26(6): 843-852.
  • 7Yi T, BaekJ-H, Kim HJ, et al. Trichostatin A-mediated upregulation of p21(WAF1) contributes to osteoclast apoptosis[J]. Exp Mol Med, 2007, 39(2): 213-221.
  • 8Lee CJ, Kim HT, Song KW, et al. Ovarian expression of p53 and p21 apoptosis regulators in gamma-irradiated mice[J]. Mol Reprod Dev, 2008, 75(2): 383-391.
  • 9Obradovic D, Tirard M, N6methy Z, et al. DAXX, FLASH, and FAF-1 modulate mineralocorticoid and glucocorticoid receptor-mediated transcription in hippocampal cells-toward a basis for the opposite actions elicited by two nuclear receptors[J].? Mol Pharmacol, 2004, 65(3): 761-769.
  • 10Zhang Z, Zhang R. Proteasome activator PA28 gamma regulates p53 by enhancing its MDM2-mediated degradation[J]. EMBOJ, 2008, 27(6): 852-864.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部